Show
Sort by
-
Assessing the persistence and relevance of small T‐LGL clones via TRBC1 in a flowcytometric lymphoid screening tube
-
- Journal Article
- A1
- open access
Risk factors and outcome of HHV-6 infections after allogeneic hematopoietic cell transplantation
-
Fixed-duration epcoritamab in combination with bendamustine plus Rituximab (BR) for first-line (IL) treatment of follicular lymphoma (FL) : 3-year results from EPCORE NHL-2 arm 3 demonstrate deep and durable responses with manageable safety
-
Fixed-duration epcoritamab plus R-CHOP in newly diagnosed diffuse large B-cell lymphoma : EPCORE NHL-2 update
(2025) BRITISH JOURNAL OF HAEMATOLOGY. In British Journal of Haematology 206(Supplement 1). p.185-185 -
Fixed-duration epcoritamab plus R-CHOP in patients with newly diagnosed DLBCL and high IPI scores (3-5) led to sustained remissions and disease-free survival beyond 3 years : results from the EPCORE NHL-2 trial
-
- Journal Article
- A1
- open access
Epidemiological characteristics and outcome of viral respiratory tract infections in the first year after allogeneic hematopoietic cell transplantation
-
Fixed-duration epcoritamab in combination with bendamustine plus rituximab for first-line treatment of follicular lymphoma : initial results from Epcore NHL-2 Arm 3
-
Fixed-duration epcoritamab plus R-CHOP induces high complete response rates in patients with previously untreated diffuse large B-cell lymphoma with high-risk features : long-term results from the Epcore NHL-2 trial
-
- Journal Article
- A1
- open access
Impact of model-informed precision dosing in adults receiving vancomycin via continuous infusion : a randomized, controlled clinical trial
-
- Journal Article
- A1
- open access
Infectious diarrhea after allogeneic hematopoietic cell transplantation assessed by a multiplex polymerase chain reaction assay